Clinical TrialsSearch results
Number of results: 901
Other
- A Phase III Study Comparing Irinotecan, Cisplatin and Etoposide (PEI) with Nogitecan for the Treatment of Relapsed Small-Cell Lung Cancer (JCOG0605)
- Sensitive relpased small-cell lung cancer
- Japan Clinical Oncology Group(JCOG)
- 2007-09-20
Other
- A Phase III Study of ARS-1 Administration in Patients with Food Allegy
- Anaphylactic Symptoms Induced by An Oral Food Challenge Test
- Kenya Morita
- 2023-06-16
Other
- A Phase III Study of Consolidation Chemotherapy Using UFT plus Cisplatin versus Docetaxel Following Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer
- Locally Advanced Non-Small Cell Lung Cancer
- The Tokyo Cooperative Oncology Group
- 2005-11-18
Other
- A phase III study of covered versus bare metallic stents for the treatment of malignant bile duct obstruction (JIVROSG-0207)
- Malignant common bile duct obstruction
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2005-08-06
Other
- A Phase III Study of Docetaxel and S-1 versus S-1 in the Treatment of Advanced Gastric Cancer
- Gastric Cancer
- Japan Clinical Cancer Research Organization
- 2005-11-01
Other
- A Phase III Study of Intra-Arterial Hepatic Chemotherapy with 5-FU (WHF) in Patients with Liver Metastases from Colorectal Carcinoma
- Liver excision;liver metastasis cancer of colorectal cancer origin
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- 2005-08-25
Other
- A phase III, efficacy and safety study of phenobarbital sodium injection in newborns with neonatal convulsion
- neonatal convulsion
- Kagawa University, University Hospital
- 2006-04-26
Recruiting
- A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-Center Study to Evaluate the Efficacy and Safety of nemolizumab in Japanese Infant and Pediatric Atopic Dermatitis Patients with moderate to severe pruritus
- Pruritus of atopic dermatitis which is inadequately controlled by the currently available therapy
- Nishiura Tomoyuki
- 2023-06-25
Not yet recruiting
- A Phase III, Two-Arm, Parallel, Randomized, Multi-Center, Open-Label, Global Study to Determine the Efficacy of Volrustomig (MEDI5752) Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy for First-Line Treatment of Patients With Metastatic Non-Small Cell Lung Cancer (mNSCLC).
- Non-small Cell Lung Cancer
- Hibi Kazushige
- 2024-03-06